Clay Jorgenson, PYD in Lindon, UT - Psychologist

Clay Jorgenson, PYD is a Psychologist - Clinical based in Lindon, Utah. Clay Jorgenson is licensed to practice in Utah (license number 11959255-2501) and his current practice location is 595 N Locust Ave, Lindon, Utah. He can be reached at his office (for appointments etc.) via phone at (801) 717-5131.

NPI number for Clay Jorgenson is 1184220766 and his current mailing address is 595 N Locust Ave, Lindon, Utah. He does not participate in medicare program and thus does not accept medicare assignments. His NPI Number is 1184220766.

Contact Information

	Clay Jorgenson, PYD
	595 N Locust Ave, Lindon, UT 84042-1316
	(801) 717-5131
	Not Available

Healthcare Provider's Profile

Full Name	Clay Jorgenson
Gender	Male
Speciality	Psychologist - Clinical
Location	595 N Locust Ave, Lindon, Utah
Accepts Medicare Assignments	Does not participate in Medicare Program. He may not accept medicare assignment.

NPI Data:

NPI Number: 1184220766
Provider Enumeration Date: 12/08/2020
Last Update Date: 12/08/2020

Medical Identifiers

Medical identifiers for Clay Jorgenson such as npi, medicare ID, medicare PIN, medicaid, etc.

Identifier	Type	State	Issuer
1184220766	NPI	-	NPPES

Medical Taxonomies and Licenses

Taxonomy	Type	License (State)	Status
103TC0700X	Psychologist - Clinical	11959255-2501 (Utah)	Primary

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Clay Jorgenson is NOT enrolled with medicare and thus cannot prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing Address	Practice Location Address
Clay Jorgenson, PYD 595 N Locust Ave, Lindon, UT 84042-1316 Ph: (801) 717-5131	Clay Jorgenson, PYD 595 N Locust Ave, Lindon, UT 84042-1316 Ph: (801) 717-5131

News Archive

UCLA researchers find link between brain cancer and fatty acid synthesis

Inhibiting fatty acid synthesis in brain cancer cells may offer a new option to treat about 50 percent of deadly glioblastomas that are driven by amplified signaling of the epidermal growth factor receptor (EGFR), according to a first-of-its-kind study by researchers at UCLA's Jonsson Comprehensive Cancer Center.

New data analysis technique improves monitoring of kidney patients

A new data analysis technique radically improves monitoring of kidney patients, according to a University of Leeds-led study, and could lead to profound changes in the way we understand our health.

HIV/AIDS prevention, treatment efforts should include care for other diseases, experts say

"Global HIV/AIDS prevention and treatment efforts are missing a major opportunity to significantly improve health conditions in poor countries by simply adding low-cost care for the many other chronic and disabling diseases routinely afflicting and often killing these same patients, according to a panel of disease experts who spoke at the annual meeting of the American Society of Tropical Medicine and Hygiene (ASTMH)," an ASTMH press release states.

UK doctors' and the public's attitudes differ over euthanasia, physician-assisted suicide

A review of research carried out over 20 years suggests that UK doctors appear to consistently oppose euthanasia and physician-assisted suicide (PAS). The findings - which appear in the latest issue of the journal Palliative Medicine, published by SAGE - highlight a gap between doctors' attitudes and those of the UK public.

Attempts to reunite separated families should not misuse medical tests, says ACP

In a new policy issued today, the American College of Physicians (ACP) stated that immigrant families who have been separated at the border should be reunited as expeditiously as possible.

Clay Jorgenson, PYD - Psychologist in Lindon, UT